Intermountain

R1 Releases Fourth Annual Environmental, Social and Governance (ESG) Report

Retrieved on: 
Wednesday, March 27, 2024
Health, Annual report, Culture, Organization, Intermountain, Human Rights Campaign, ESG, Patient, RCM, Form 10-K, Bank statement, Social, Reliability-centered maintenance, Tree, Workplace, U.N, Management

MURRAY, Utah, March 27, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, has released its 2023 Environmental, Social and Governance (ESG) report .

Key Points: 
  • MURRAY, Utah, March 27, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, has released its 2023 Environmental, Social and Governance (ESG) report .
  • The report details the company’s commitment to improving access to healthcare, bringing responsible global citizenship to life through its ESG program.
  • R1 does not undertake to update its forward-looking statements except to the extent required by applicable law.
  • All forward-looking statements included herein are expressly qualified in their entirety by these cautionary statements.

InStride Celebrates Five Years of Growth, Innovation and Social Impact

Retrieved on: 
Wednesday, March 20, 2024
SSM Health, Arizona State University, L&D, Intelligence, Partnership, Aramark, Intermountain, Education, Health, Intermountain Health, Medtronic, NPS, Workforce, Rochester Regional Health, Tutoring

“Through a unique partnership between Arizona State University and TPG’s The Rise Fund, InStride was founded to help solve America’s talent and student debt challenges through employer-sponsored education programs,” said Craig Maloney, Chief Executive Officer at InStride.

Key Points: 
  • “Through a unique partnership between Arizona State University and TPG’s The Rise Fund, InStride was founded to help solve America’s talent and student debt challenges through employer-sponsored education programs,” said Craig Maloney, Chief Executive Officer at InStride.
  • More recently, InStride launched InSkilling TM as a solution for employers to expand talent pools by replacing traditional degree requirements with skills-based hiring.
  • "Our partnership with InStride has enabled us to remove barriers to growth opportunities for our talent and increase retention with our Medtronic MAPS workforce education program.
  • “InStride has never been stronger and our distinctive combination of services and solutions are poised to deliver remarkable innovation for the modern workforce,” said Maloney.

Fabric Genomics Partners with Intermountain Children’s Health to Enhance Precision Diagnosis of Infants and Children Using Whole Genome Sequencing from Broad Clinical Labs

Retrieved on: 
Wednesday, March 13, 2024
Health Technology, Data Management, Other Health, Technology, Practice Management, Hospitals, Genetics, Parenting, Artificial Intelligence, Baby, Maternity, Biotechnology, Science, Software, Other Science, Consumer, Health, Diagnosis, WGS, Genomics, Ventricular septal defect, Database, Entrepreneurship, CICU, DSM-IV codes, Intelligence, Partnership, Intermountain, Physician, Patient, Knowledge, Research, Intermountain Health, Infant, University, Doctor of Philosophy, MD, CHD, Medicine, Phenotype, Hospital, Whole genome sequencing, Multimedia, Pediatrics, Nursing

The sample-to-report genome service enables healthcare professionals to identify genetic disorders with unprecedented speed and precision and to tailor treatment plans to the unique genetic makeup of each infant.

Key Points: 
  • The sample-to-report genome service enables healthcare professionals to identify genetic disorders with unprecedented speed and precision and to tailor treatment plans to the unique genetic makeup of each infant.
  • Offered by partners Broad Clinical Labs and Fabric Genomics, the sample-to-report genomic analysis service makes whole genome sequencing (WGS) and diagnosis accessible to healthcare systems who may not currently have genomics infrastructure and expertise in-house.
  • The partnership between Broad Clinical Labs and Fabric Genomics addresses the critical need for affordable, accurate genomic insights, particularly for infants undergoing surgical repair of congenital heart disease (CHD).
  • "We are excited to integrate the Broad Clinical Labs’ whole genome sequencing service and Fabric’s Enterprise software platform into the clinical workflow within our pediatric cardiac intensive care unit (CICU).

Sworkit Health and Select Health Collaborate to Promote CDC's Physical Fitness Guidelines Among Health Plan Members and Intermountain Health Employees

Retrieved on: 
Tuesday, March 26, 2024
Mindfulness, Reward, Health, Culture, Health promotion, Caregiver, Intermountain, Yoga, Intermountain Health, Pulse, Meditation, CDC, Physical fitness, Virgin Group, MSK

This relationship underscores a commitment to enhancing the health and well-being of Intermountain Health caregivers and Select Health members by promoting physical fitness and overall health outcomes.

Key Points: 
  • This relationship underscores a commitment to enhancing the health and well-being of Intermountain Health caregivers and Select Health members by promoting physical fitness and overall health outcomes.
  • This initiative has led to a remarkable achievement: a 50% engagement rate among Intermountain Health employees, doubling the participation compared to non-incentivized programs.
  • "We are thrilled to collaborate with Intermountain Health and Select Health through the Virgin Pulse platform to support their employees and members in achieving their health and fitness goals.
  • "Our collaboration with Sworkit Health has sparked active involvement among our caregivers at Intermountain Health and our Select Health members, aligning with our mission of helping people live the healthiest lives possible," said Jeremy Drecksel, director of health promotion and wellness at Select Health.

Mountain America Partners in Building the New Ronald McDonald House

Retrieved on: 
Tuesday, March 5, 2024
Intermountain, Caregiver, RMHC, Hospital, Mountain America Credit Union, University, PCH, House, Charitable organization, Patient, Ronald McDonald House Charities, Trauma, Family room, Environment, Partnership, Nursing

The Leading with Love campaign is a significant fundraising effort that demonstrates Mountain America’s continued commitment to the vision and mission of RMHC.

Key Points: 
  • The Leading with Love campaign is a significant fundraising effort that demonstrates Mountain America’s continued commitment to the vision and mission of RMHC.
  • “We are honored to partner with Ronald McDonald House Charities to support the Ronald McDonald Family Room at the new Intermountain Primary Children's Hospital in Lehi,” said Sterling Nielsen, president and CEO of Mountain America Credit Union.
  • In fact, this Ronald McDonald Family Room is the fourth Ronald McDonald Family Room program located directly inside Intermountain Primary Children’s Hospitals.
  • For more information about Ronald McDonald House Charities of the Intermountain Area, please visit: https://www.rmhcslc.org/
    For more information about the new Miller Campus of Primary Children’s Hospital, please visit: https://intermountainhealthcare.org/primary-childrens/about/lehi-campus

Bipartisan Representatives Introduce MATCH IT Act of 2024

Retrieved on: 
Friday, February 16, 2024
Hospital, Patient, Intermountain Health, Doctor of Philosophy, Roger Hawkins (drummer), CHIME, HIMSS, ID, Digital, MBA, Chairperson, Death, Information, Safety, AHIMA, Health, Approximation error, Organization, Legislation, Patient safety, Privacy, Congress, Representative, MATCH, Intermountain, Medical device

The MATCH IT Act would address the problem of patient misidentification within the healthcare ecosystem while improving patient safety and privacy.

Key Points: 
  • The MATCH IT Act would address the problem of patient misidentification within the healthcare ecosystem while improving patient safety and privacy.
  • Patient misidentification within the US healthcare system has long threatened patient safety and privacy and is a driver of unnecessary costs to patients and providers.
  • “The MATCH IT Act would help decrease rates of misidentification, improve patient privacy and patient care through a standardization of patient information, and allow records to be matched more accurately.
  • Intermountain Health salutes long-time congressional champions on patient matching, Representatives Mike Kelly of Pennsylvania and Bill Foster of Illinois.”

Caregivers Cheer First Patients at New Intermountain Primary Children’s Hospital, Miller Family Campus in Lehi, Utah

Retrieved on: 
Monday, February 12, 2024
Intermountain West, MOGAD, Liver, Child, Central nervous system, Ulcerative colitis, Caregiver, Gymnastics, Intermountain Health, Courage, Friends, Basketball, Hospital, Primary sclerosing cholangitis, Hope, Communication, Bile, Arthralgia, University, Life flight, Nursing, Patient, Myasthenia gravis, Optic nerve, Biology, Intermountain, Football, Environment

The Miller Family Campus’ Infusion Center opened for one day before the grand opening to give them the treatments they needed, closer to home.

Key Points: 
  • The Miller Family Campus’ Infusion Center opened for one day before the grand opening to give them the treatments they needed, closer to home.
  • Everyone at the new campus has been so amazing to work with!”
    The new Miller Family Campus is a full-service children’s hospital providing nearly all the same specialty pediatric services that patients receive at the Salt Lake Campus.
  • The Miller Family Campus is part of Intermountain Health’s Primary Promise to build the nation’s model health system for children.
  • For more information about the new Miller Family Campus in Lehi, visit primarychildrens.org/lehi .

Myriad Genetics to Acquire Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics

Retrieved on: 
Thursday, January 18, 2024
Neoplasm, LCD, Myriad Genetics, Patient, Intermountain, DNA, Medicare, RNA, Myriad, Genetics, Genetic testing, Acquisition, MYGN, Intermountain Health, IPG, Medicine, Growth, Pharmaceutical industry

SALT LAKE CITY, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced it has entered into a definitive agreement to acquire select assets from Intermountain Precision Genomics’ (IPG) laboratory business, including the Precise™ Tumor Test, the Precise Liquid Test, and IPG’s CLIA-certified laboratory in St. George, Utah where the Precise Tumor Test is currently performed.

Key Points: 
  • SALT LAKE CITY, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced it has entered into a definitive agreement to acquire select assets from Intermountain Precision Genomics’ (IPG) laboratory business, including the Precise™ Tumor Test, the Precise Liquid Test, and IPG’s CLIA-certified laboratory in St. George, Utah where the Precise Tumor Test is currently performed.
  • By bringing the Precise Tumor and Precise Liquid tests in house, Myriad will open up new opportunities for innovation, growth, and continued development of its oncology portfolio.
  • Upon the closing of the acquisition on February 1, 2024, Myriad expects to operate TheraMap: Solid Tumor solely as Precise Tumor.
  • The financial terms of the deal were not disclosed but are not material to either Myriad or Intermountain Healthcare.

Hyundai and Salt Lake City Hyundai Dealers Raise $70,000 in Support of Intermountain Primary Children's Hospital through KSL Give-A-Thon

Retrieved on: 
Tuesday, November 7, 2023
Hyundai Motor Company, Progress in Human Geography, Cohen Children's Medical Center, Intermountain, Health, Heart, University of Utah School of Medicine, Hyundai Motor America, Primary Children's Hospital, Intermountain Health, Bone marrow, Humanity, Liver, Kidney, Research, SALT, Multimedia, Intermountain West, Child, SUV, Hyundai Motor Manufacturing Alabama, University, KSL, Hyundai, Patient, Philosophy, Hospital, Transplant, Automotive industry, Nursing

SALT LAKE CITY, Nov. 7, 2023 /PRNewswire/ -- Hyundai Motor America and six Salt Lake City area Hyundai dealers donated $70,000 to Intermountain Primary Children's Hospital as part of the KSL Give-A-Thon 2023.

Key Points: 
  • SALT LAKE CITY, Nov. 7, 2023 /PRNewswire/ -- Hyundai Motor America and six Salt Lake City area Hyundai dealers donated $70,000 to Intermountain Primary Children's Hospital as part of the KSL Give-A-Thon 2023.
  • KSL NewsRadio and TV stations along with several others teamed up to raise awareness and critical funds for Primary Children's Hospital in Salt Lake City, Utah.
  • "Salt Lake City Hyundai dealers are proud to sponsor and donate to the KSL Give-A-Thon in support of Primary Children's Hospital," said Blake Murdock, dealer principal, Murdock Auto Team.
  • Intermountain Primary Children's Hospital in Salt Lake City is a full-service children's hospital serving Utah, Idaho, Wyoming, Nevada, Montana and Alaska.

Genomenon Takes a Leap in the Race to Curate the Genome

Retrieved on: 
Thursday, November 2, 2023
ASHG, Genetic testing, Catalog, WES, Intermountain, Intermountain Health, MD, Software, Society, Genomics, Genome, Mastermind, American Society of Human Genetics, Disease, Risk, WGS, Workflow, Gene, Reasoned action approach, ANN, Patient, Doctor of Philosophy, Diagnosis, Antibiotics, Medical device

ANN ARBOR, Mich., Nov. 2, 2023 /PRNewswire-PRWeb/ -- Genomenon Inc., a leading genomic intelligence company, today announced the first milestone in its journey to curate the human genome with the release of Mastermind 3.0, now including the clinical exome fully curated at the gene level. With this latest launch of its Mastermind Platform, Genomenon is delivering a comprehensive catalog of more than 9,000 gene-disease relationships across 5,500 genes, with more being added each week. These curations, based on ClinGen recommendations, are useful to accelerate novel variant curation, especially in large panels, whole exomes (WES), and whole genomes (WGS). The company is the first to curate the clinical exome at the gene level based on ClinGen guidelines, considered the highest industry standard.

Key Points: 
  • The company is the first to curate the clinical exome at the gene level based on ClinGen guidelines, considered the highest industry standard.
  • As next-generation sequencing technology advances, whole exome and genome testing is quickly replacing less comprehensive methods to identify disease in patients.
  • The latest release of our platform represents a significant milestone in our work to curate the human genome and simplify complex genetic data into actionable insights."
  • Dr. Kiel will also be presenting on November 3, in a session "Understanding Gene-Disease Relationships: A Novel and Actionable Approach".